Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vaccines
Researchers from La Jolla Institute for Allergy and Immunology publish new studies and findings in the area of vaccines
July 2nd, 2008
New investigation results, 'Selective CD4+ T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities,' are detailed in a study published in Immunity. According to a study from the United States, "Antibody responses are critical components of protective immune responses to many pathogens, but parameters determining which proteins are targeted remain unclear. Vaccination with individual MHC-II-restricted vaccinia virus (VACV, smallpox vaccine) epitopes revealed that CD4(+) T cell help to B cells was surprisingly nontransferable to other virion protein specificities." "Many VACV CD4(+) T cell responses identified in an...
Source: Vaccine Weekly (2008-07-02)
|
